137 related articles for article (PubMed ID: 18339433)
1. A sensitive and quantitative assay for normal PrP in plasma.
Gregori L; Gray BN; Rose E; Spinner DS; Kascsak RJ; Rohwer RG
J Virol Methods; 2008 May; 149(2):251-9. PubMed ID: 18339433
[TBL] [Abstract][Full Text] [Related]
2. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
3. Detection of prion protein using a capillary electrophoresis-based competitive immunoassay with laser-induced fluorescence detection and cyclodextrin-aided separation.
Yang WC; Yeung ES; Schmerr MJ
Electrophoresis; 2005 May; 26(9):1751-9. PubMed ID: 15815999
[TBL] [Abstract][Full Text] [Related]
4. Surround optical fiber immunoassay (SOFIA): an ultra-sensitive assay for prion protein detection.
Chang B; Gray P; Piltch M; Bulgin MS; Sorensen-Melson S; Miller MW; Davies P; Brown DR; Coughlin DR; Rubenstein R
J Virol Methods; 2009 Jul; 159(1):15-22. PubMed ID: 19442839
[TBL] [Abstract][Full Text] [Related]
5. A rapid method for detection of PrP by surface plasmon resonance (SPR).
Jiayu W; Xiong W; Jiping L; Wensen L; Ming X; Linna L; Jing X; Haiying W; Hongwei G
Arch Virol; 2009; 154(12):1901-8. PubMed ID: 19862471
[TBL] [Abstract][Full Text] [Related]
6. Detection of misfolded prion protein in blood with conformationally sensitive peptides.
Pan T; Sethi J; Nelsen C; Rudolph A; Cervenakova L; Brown P; Orser CS
Transfusion; 2007 Aug; 47(8):1418-25. PubMed ID: 17655586
[TBL] [Abstract][Full Text] [Related]
7. Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands.
Gregori L; Lambert BC; Gurgel PV; Gheorghiu L; Edwardson P; Lathrop JT; Macauley C; Carbonell RG; Burton SJ; Hammond D; Rohwer RG
Transfusion; 2006 Jul; 46(7):1152-61. PubMed ID: 16836562
[TBL] [Abstract][Full Text] [Related]
8. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
9. Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR.
Barletta JM; Edelman DC; Highsmith WE; Constantine NT
J Virol Methods; 2005 Aug; 127(2):154-64. PubMed ID: 15921765
[TBL] [Abstract][Full Text] [Related]
10. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of PrPSc by Western blot assay based on streptomycin sulphate precipitation.
Dong CF; Huang YX; An R; Chen JM; Wang XF; Shan B; Lei YJ; Han L; Zhang BY; Han J; Dong XP
Zoonoses Public Health; 2007; 54(8):328-36. PubMed ID: 17894644
[TBL] [Abstract][Full Text] [Related]
13. Simple and specific detection of abnormal prion protein by a magnetic bead-based immunoassay coupled with laser-induced fluorescence spectrofluorometry.
Kim JI; Wang C; Kuizon S; Xu J; Barengolts D; Gray PC; Rubenstein R
J Neuroimmunol; 2005 Jan; 158(1-2):112-9. PubMed ID: 15589044
[TBL] [Abstract][Full Text] [Related]
14. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins.
Gregori L; Gurgel PV; Lathrop JT; Edwardson P; Lambert BC; Carbonell RG; Burton SJ; Hammond DJ; Rohwer RG
Lancet; 2006 Dec; 368(9554):2226-30. PubMed ID: 17189034
[TBL] [Abstract][Full Text] [Related]
15. TSE clearance during plasma products separation process by Gradiflow(TM).
Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H
Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286
[TBL] [Abstract][Full Text] [Related]
16. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
[TBL] [Abstract][Full Text] [Related]
17. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein.
Lee DC; Stenland CJ; Hartwell RC; Ford EK; Cai K; Miller JL; Gilligan KJ; Rubenstein R; Fournel M; Petteway SR
J Virol Methods; 2000 Jan; 84(1):77-89. PubMed ID: 10644089
[TBL] [Abstract][Full Text] [Related]
18. Partitioning of TSE infectivity during ethanol fractionation of human plasma.
Gregori L; Maring JA; MacAuley C; Dunston B; Rentsch M; Kempf C; Rohwer RG
Biologicals; 2004 Mar; 32(1):1-10. PubMed ID: 15026020
[TBL] [Abstract][Full Text] [Related]
19. Rapid presymptomatic detection of PrPSc via conformationally responsive palindromic PrP peptides.
Grosset A; Moskowitz K; Nelsen C; Pan T; Davidson E; Orser CS
Peptides; 2005 Nov; 26(11):2193-200. PubMed ID: 16269350
[TBL] [Abstract][Full Text] [Related]
20. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
Dabaghian RH; Barnard G; McConnell I; Clewley JP
J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
